ATE109975T1 - Pharmazeutische formulierungen mit anhaltender freisetzung. - Google Patents

Pharmazeutische formulierungen mit anhaltender freisetzung.

Info

Publication number
ATE109975T1
ATE109975T1 AT90401648T AT90401648T ATE109975T1 AT E109975 T1 ATE109975 T1 AT E109975T1 AT 90401648 T AT90401648 T AT 90401648T AT 90401648 T AT90401648 T AT 90401648T AT E109975 T1 ATE109975 T1 AT E109975T1
Authority
AT
Austria
Prior art keywords
sustained release
pharmaceutical formulations
release pharmaceutical
ketoprofen
awater
Prior art date
Application number
AT90401648T
Other languages
English (en)
Inventor
Gordon Thomas Simpkin
Isabelle Husson
Original Assignee
Rhone Poulenc Sante
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Sante filed Critical Rhone Poulenc Sante
Application granted granted Critical
Publication of ATE109975T1 publication Critical patent/ATE109975T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
AT90401648T 1989-06-16 1990-06-14 Pharmazeutische formulierungen mit anhaltender freisetzung. ATE109975T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB898913889A GB8913889D0 (en) 1989-06-16 1989-06-16 New compositions of matter

Publications (1)

Publication Number Publication Date
ATE109975T1 true ATE109975T1 (de) 1994-09-15

Family

ID=10658565

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90401648T ATE109975T1 (de) 1989-06-16 1990-06-14 Pharmazeutische formulierungen mit anhaltender freisetzung.

Country Status (9)

Country Link
US (1) US5188841A (de)
EP (1) EP0403383B1 (de)
JP (1) JPH0363220A (de)
AT (1) ATE109975T1 (de)
CA (1) CA2019108A1 (de)
DE (1) DE69011588T2 (de)
DK (1) DK0403383T3 (de)
ES (1) ES2068353T3 (de)
GB (1) GB8913889D0 (de)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6197347B1 (en) 1998-06-29 2001-03-06 Andrx Pharmaceuticals, Inc. Oral dosage for the controlled release of analgesic
ES2168043B1 (es) * 1999-09-13 2003-04-01 Esteve Labor Dr Forma farmaceutica solida oral de liberacion modificada que contiene un compuesto de bencimidazol labil en medio acido.
EP1252886A1 (de) * 2001-04-27 2002-10-30 Universiteit Gent Pharmazeutische Pelletformulierungen für eine kontrollierte Freisetzung
GB0025208D0 (en) * 2000-10-13 2000-11-29 Euro Celtique Sa Delayed release pharmaceutical formulations
WO2002055009A1 (en) * 2001-01-12 2002-07-18 Sun Pharmaceutical Industries Limited Spaced drug delivery system
JP5328071B2 (ja) * 2001-04-10 2013-10-30 サン・ファーマ・アドバンスド・リサーチ・カンパニー・リミテッド 時限パルス放出組成物
US20040146561A1 (en) 2001-05-23 2004-07-29 Naoki Sakurai Compositions for promoting healing of bone fracture
CN1537018A (zh) 2001-05-23 2004-10-13 田边制药株式会社 一种用于软骨疾病再生治疗的组合物
AR036797A1 (es) 2001-10-15 2004-10-06 Ferring Bv Un metodo para preparar una composicion farmaceutica que comprende acido 5-aminosalicilico para utilizar en el tratamiento de colitis ulcerosa y enfermedades de crohn
GB0205253D0 (en) 2002-03-06 2002-04-17 Univ Gent Immediate release pharmaceutical granule compositions and a continuous process for making them
FR2842735B1 (fr) * 2002-07-26 2006-01-06 Flamel Tech Sa Microcapsules a liberation modifiee de principes actifs peu solubles pour l'administration per os
KR100628263B1 (ko) * 2002-08-21 2006-09-27 엘지.필립스 엘시디 주식회사 액정표시소자
WO2004108067A2 (en) * 2003-04-03 2004-12-16 Sun Pharmaceutical Industries Limited Programmed drug delivery system
WO2004093883A2 (en) 2003-04-23 2004-11-04 Ferring B.V. Sachet for a pharmaceutical composition
WO2004112756A1 (en) 2003-06-26 2004-12-29 Isa Odidi Proton pump-inhibitor-containing capsules which comprise subunits differently structured for a delayed release of the active ingredient
US8273371B2 (en) 2003-06-27 2012-09-25 Johan Adriaan Martens Crystalline mesoporous oxide based materials useful for the fixation and controlled release of drugs
GB0315012D0 (en) 2003-06-27 2003-07-30 Leuven K U Res & Dev Zeotiles
EP1547601A1 (de) * 2003-12-23 2005-06-29 Ferring B.V. Beschichtungsverfahren
US8394409B2 (en) 2004-07-01 2013-03-12 Intellipharmaceutics Corp. Controlled extended drug release technology
US10624858B2 (en) 2004-08-23 2020-04-21 Intellipharmaceutics Corp Controlled release composition using transition coating, and method of preparing same
US10064828B1 (en) 2005-12-23 2018-09-04 Intellipharmaceutics Corp. Pulsed extended-pulsed and extended-pulsed pulsed drug delivery systems
US8815285B2 (en) * 2006-03-28 2014-08-26 Wockhardt Ltd. Extended release dosage forms of metoprolol
EP1839649A1 (de) * 2006-03-31 2007-10-03 LEK Pharmaceuticals D.D. Beschichtete Formulierung von Tolterodine
US9561188B2 (en) * 2006-04-03 2017-02-07 Intellipharmaceutics Corporation Controlled release delivery device comprising an organosol coat
US10960077B2 (en) 2006-05-12 2021-03-30 Intellipharmaceutics Corp. Abuse and alcohol resistant drug composition
EP1935405A1 (de) * 2006-12-22 2008-06-25 LEK Pharmaceuticals D.D. Im Mund zerfallende Tabletten
EP2144599B1 (de) * 2007-03-02 2010-08-04 Farnam Companies, Inc. Wachsähnliches material enthaltende tabletten mit verzögerter freisetzung
US10668012B2 (en) * 2008-09-04 2020-06-02 Farnam Companies, Inc. Chewable sustained release formulations
CN102813638A (zh) * 2011-06-07 2012-12-12 贵阳医学院 一种右旋酮洛芬氨丁三醇双层缓释片的制备方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA765931B (en) * 1975-10-10 1977-09-28 Squibb & Sons Inc Controlled release tablet
GB1561204A (en) * 1977-06-01 1980-02-13 Ici Ltd Sustained release pharmaceutical composition
DD146547A5 (de) * 1978-07-15 1981-02-18 Boehringer Sohn Ingelheim Arzneimittel-retardform mit unloeslichen poroesen diffusionshuellen
JPS5535031A (en) * 1978-09-04 1980-03-11 Shin Etsu Chem Co Ltd Enteric coating composition
US4309406A (en) * 1979-07-10 1982-01-05 American Home Products Corporation Sustained release pharmaceutical compositions
US4369172A (en) * 1981-12-18 1983-01-18 Forest Laboratories Inc. Prolonged release therapeutic compositions based on hydroxypropylmethylcellulose
SE457505B (sv) * 1984-01-10 1989-01-09 Lejus Medical Ab Laminatbelagd oral farmaceutisk komposition och foerfarande foer dess framstaellning
IE861284L (en) * 1986-05-14 1987-11-14 Birex Res And Dev Ltd And Carm Controlled release ketoprofen.
GB8702411D0 (en) * 1987-02-03 1987-03-11 Zyma Sa Swellable pellets
GB8705083D0 (en) * 1987-03-04 1987-04-08 Euro Celtique Sa Spheroids
GB8724763D0 (en) * 1987-10-22 1987-11-25 Aps Research Ltd Sustained-release formulations

Also Published As

Publication number Publication date
EP0403383B1 (de) 1994-08-17
ES2068353T3 (es) 1995-04-16
DK0403383T3 (da) 1994-09-12
EP0403383A1 (de) 1990-12-19
DE69011588D1 (de) 1994-09-22
US5188841A (en) 1993-02-23
DE69011588T2 (de) 1994-12-15
GB8913889D0 (en) 1989-08-02
CA2019108A1 (en) 1990-12-16
JPH0363220A (ja) 1991-03-19

Similar Documents

Publication Publication Date Title
ATE109975T1 (de) Pharmazeutische formulierungen mit anhaltender freisetzung.
FR2683146B1 (fr) Compositions pharmaceutiques a liberation reglee de la substance medicamenteuse.
DE69231965D1 (de) Pharmazeutische formulierungen
DE69525148D1 (de) Pharmazeutische formulierung
NO308303B1 (no) Vannløselige rapamycinestere, anvendelse derav samt farmasøytisk blanding som omfatter forbindelsene
ATE221374T1 (de) Lyophilisierte stabile pharmazeutische formulierung
FR2624732B1 (fr) Formulation pharmaceutique a liberation prolongee
DE69621885D1 (de) Neue galenische orale pharmazeutische formulierung
BR9610153A (pt) Formulações farmacêuticas
BR9611626A (pt) Formulações farmacéuticas
MA26576A1 (fr) Formulation pharmaceutique orale a liberation prolongee
FI973471A (fi) Pyratsol-4-yylibentsoyylijohdoksia ja niiden käyttö herbisideinä
MA26577A1 (fr) Formulation pharmaceutique orale a liberation pulsee
DE69812089D1 (de) Pharmazeutische omeprazol-formulierung
ES2020277B3 (es) Formulacion para la liberacion sostenida de ibuprofen.
BR9610396A (pt) Formulação farmacêutica
FI925778A (fi) Farmaceutiskt aktiva bensokinazolinfoereningar
AU1495595A (en) Sustained-release dosage forms of alfuzosin hydrochloride
DZ1926A1 (fr) Formulations pharmaceutiques.
NO975567D0 (no) Preparat med kontrollert frigivelse av aktiv substans
AU6090790A (en) Microencapsulated taste-masked water-insoluble nsaid drug materials
DK0861025T3 (da) Pesticidformuleringer
FI973230A (fi) Uusi farmaseuttinen formulaatio
DE69632787D1 (de) Pharmazeutische pellets
ATE142880T1 (de) Penciclovir enthaltende pharmazeutische formulierung

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee